Match tier
Confirmed
Presence
Current · Arkansas
Last published
2026
Sources
OpenAlex · ORCID
Refreshed
2026-10-05
C. Phillips
Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.
Associate Professor
Obstetrics & Gynecology, College of Medicine
11 h-index
21 pubs
461 cited
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Amy Phillips, MD, is an Associate Professor in the Department of Obstetrics and Gynecology at the University of Arkansas for Medical Sciences (UAMS). She completed her medical degree and residency at UAMS, receiving recognition for her teaching during her residency. Dr. Phillips currently serves as the Residency Program Director for the UAMS Department of Obstetrics and Gynecology.
Her research interests include investigating the use of electronic cigarettes in pregnancy and exploring therapeutic vaccines for cervical intraepithelial neoplasia. She has also contributed to studies on the compositional assessment of genetically modified maize and methods for determining pesticide metabolites in environmental matrices. Dr. Phillips is a member of the Alpha Omega Alpha Honor Medical Society.
Research Overview
Amy Phillips, MD, is an Associate Professor in the UAMS Department of Obstetrics and Gynecology. She graduated summa cum laude from the University of Arkansas for Medical Sciences in 2004 then completed her residency in the UAMS Department of Obstetrics and Gynecology in 2008. Her dedication to education was recognized with a Resident Excellence in Teaching Award, and she currently serves as Residency Program Director. She is also a member of Alpha Omega Alpha Honor Medical Society. Dr. Phillips looks forward to many years of excellence in practicing medicine, teaching and research for UAMS.
Metrics
- h-index: 11
- Publications: 21
- Citations: 461
Selected Publications
-
Nonalcoholic Steatohepatitis (NASH) and Nonalcoholic Fatty Liver Disease (NALFD) in Pregnancy: A Narrative Review (2026)
-
Macronutrient and Energy Intake Across Three Pregnancy Trimesters Among a Cohort of Arkansas Women Enrolled in the Glowing Study (2025)
-
Restless Leg Syndrome and Pregnancy (2025)
-
Management and Interventions in Previable and Periviable Preterm Premature Rupture of Membranes: A Review (2023)
-
Alternate Birth Strategies (2023)
-
Birth plans: definitions, content, effects, and best practices (2023)
-
17 Alpha-hydroxyprogesterone caproate use in a rural state (2021)
-
A phase I dose-escalation clinical trial of a peptide-based human papillomavirus therapeutic vaccine with candida skin test reagent as a novel vaccine adjuvant for treating women with biopsy-proven cervical intraepithelial neoplasia 2/3. (2015)
-
A phase I dose-escalation clinical trial of a peptide-based human papillomavirus therapeutic vaccine with Candida skin test reagent as a novel vaccine adjuvant for treating women with biopsy-proven cervical intraepithelial neoplasia 2/3 (2015)
-
Estimate of fetal weight by ultrasound within two weeks of delivery in the detection of fetal macrosomia (2014)
Collaboration Network
Top Collaborators
Everett F. Magann
University of Arkansas for Medical Sciences
6 shared publications
In database
- Birth plans: definitions, content, effects, and best practices
- Management and Interventions in Previable and Periviable Preterm Premature Rupture of Membranes: A Review
- Estimate of fetal weight by ultrasound within two weeks of delivery in the detection of fetal macrosomia
- Alternate Birth Strategies
- Restless Leg Syndrome and Pregnancy
Showing 5 of 6 shared publications
Nirvana Manning
University of Arkansas for Medical Sciences
3 shared publications
In database
- A phase I dose-escalation clinical trial of a peptide-based human papillomavirus therapeutic vaccine with Candida skin test reagent as a novel vaccine adjuvant for treating women with biopsy-proven cervical intraepithelial neoplasia 2/3
- Restless Leg Syndrome and Pregnancy
- A phase I dose-escalation clinical trial of a peptide-based human papillomavirus therapeutic vaccine with candida skin test reagent as a novel vaccine adjuvant for treating women with biopsy-proven cervical intraepithelial neoplasia 2/3.
Taylor Ghahremani
University of Arkansas for Medical Sciences
3 shared publications
In database
- Birth plans: definitions, content, effects, and best practices
- Alternate Birth Strategies
- 17 Alpha-hydroxyprogesterone caproate use in a rural state
Julie R. Whittington
Naval Medical Center Portsmouth (US)
3 shared publications
- Birth plans: definitions, content, effects, and best practices
- Alternate Birth Strategies
- 17 Alpha-hydroxyprogesterone caproate use in a rural state
William W. Greenfield
University of Arkansas for Medical Sciences
2 shared publications
In database
- A phase I dose-escalation clinical trial of a peptide-based human papillomavirus therapeutic vaccine with Candida skin test reagent as a novel vaccine adjuvant for treating women with biopsy-proven cervical intraepithelial neoplasia 2/3
- A phase I dose-escalation clinical trial of a peptide-based human papillomavirus therapeutic vaccine with candida skin test reagent as a novel vaccine adjuvant for treating women with biopsy-proven cervical intraepithelial neoplasia 2/3.
Shawna L. Stratton
University of Arkansas for Medical Sciences (US)
2 shared publications
- A phase I dose-escalation clinical trial of a peptide-based human papillomavirus therapeutic vaccine with Candida skin test reagent as a novel vaccine adjuvant for treating women with biopsy-proven cervical intraepithelial neoplasia 2/3
- A phase I dose-escalation clinical trial of a peptide-based human papillomavirus therapeutic vaccine with candida skin test reagent as a novel vaccine adjuvant for treating women with biopsy-proven cervical intraepithelial neoplasia 2/3.
Rebecca S Myrick
University of Arkansas for Medical Sciences (US)
2 shared publications
- A phase I dose-escalation clinical trial of a peptide-based human papillomavirus therapeutic vaccine with Candida skin test reagent as a novel vaccine adjuvant for treating women with biopsy-proven cervical intraepithelial neoplasia 2/3
- A phase I dose-escalation clinical trial of a peptide-based human papillomavirus therapeutic vaccine with candida skin test reagent as a novel vaccine adjuvant for treating women with biopsy-proven cervical intraepithelial neoplasia 2/3.
Rita Vaughn
University of Arkansas for Medical Sciences (US)
2 shared publications
- A phase I dose-escalation clinical trial of a peptide-based human papillomavirus therapeutic vaccine with Candida skin test reagent as a novel vaccine adjuvant for treating women with biopsy-proven cervical intraepithelial neoplasia 2/3
- A phase I dose-escalation clinical trial of a peptide-based human papillomavirus therapeutic vaccine with candida skin test reagent as a novel vaccine adjuvant for treating women with biopsy-proven cervical intraepithelial neoplasia 2/3.
Lisa M. Donnalley
University of Arkansas for Medical Sciences (US)
2 shared publications
- A phase I dose-escalation clinical trial of a peptide-based human papillomavirus therapeutic vaccine with Candida skin test reagent as a novel vaccine adjuvant for treating women with biopsy-proven cervical intraepithelial neoplasia 2/3
- A phase I dose-escalation clinical trial of a peptide-based human papillomavirus therapeutic vaccine with candida skin test reagent as a novel vaccine adjuvant for treating women with biopsy-proven cervical intraepithelial neoplasia 2/3.
Hannah Coleman
University of Arkansas for Medical Sciences
2 shared publications
In database
- A phase I dose-escalation clinical trial of a peptide-based human papillomavirus therapeutic vaccine with Candida skin test reagent as a novel vaccine adjuvant for treating women with biopsy-proven cervical intraepithelial neoplasia 2/3
- A phase I dose-escalation clinical trial of a peptide-based human papillomavirus therapeutic vaccine with candida skin test reagent as a novel vaccine adjuvant for treating women with biopsy-proven cervical intraepithelial neoplasia 2/3.
Maria Mercado
University of Arkansas for Medical Sciences (US)
2 shared publications
- A phase I dose-escalation clinical trial of a peptide-based human papillomavirus therapeutic vaccine with Candida skin test reagent as a novel vaccine adjuvant for treating women with biopsy-proven cervical intraepithelial neoplasia 2/3
- A phase I dose-escalation clinical trial of a peptide-based human papillomavirus therapeutic vaccine with candida skin test reagent as a novel vaccine adjuvant for treating women with biopsy-proven cervical intraepithelial neoplasia 2/3.
A. Moerman
University of Arkansas for Medical Sciences
2 shared publications
In database
- A phase I dose-escalation clinical trial of a peptide-based human papillomavirus therapeutic vaccine with Candida skin test reagent as a novel vaccine adjuvant for treating women with biopsy-proven cervical intraepithelial neoplasia 2/3
- A phase I dose-escalation clinical trial of a peptide-based human papillomavirus therapeutic vaccine with candida skin test reagent as a novel vaccine adjuvant for treating women with biopsy-proven cervical intraepithelial neoplasia 2/3.
Horace J. Spencer
University of Arkansas for Medical Sciences
2 shared publications
In database
- A phase I dose-escalation clinical trial of a peptide-based human papillomavirus therapeutic vaccine with Candida skin test reagent as a novel vaccine adjuvant for treating women with biopsy-proven cervical intraepithelial neoplasia 2/3
- A phase I dose-escalation clinical trial of a peptide-based human papillomavirus therapeutic vaccine with candida skin test reagent as a novel vaccine adjuvant for treating women with biopsy-proven cervical intraepithelial neoplasia 2/3.
Wilbur C. Hitt
University of Arkansas for Medical Sciences (US)
2 shared publications
- A phase I dose-escalation clinical trial of a peptide-based human papillomavirus therapeutic vaccine with Candida skin test reagent as a novel vaccine adjuvant for treating women with biopsy-proven cervical intraepithelial neoplasia 2/3
- A phase I dose-escalation clinical trial of a peptide-based human papillomavirus therapeutic vaccine with candida skin test reagent as a novel vaccine adjuvant for treating women with biopsy-proven cervical intraepithelial neoplasia 2/3.
Samantha S. McKelvey
University of Arkansas for Medical Sciences
2 shared publications
In database
- A phase I dose-escalation clinical trial of a peptide-based human papillomavirus therapeutic vaccine with Candida skin test reagent as a novel vaccine adjuvant for treating women with biopsy-proven cervical intraepithelial neoplasia 2/3
- A phase I dose-escalation clinical trial of a peptide-based human papillomavirus therapeutic vaccine with candida skin test reagent as a novel vaccine adjuvant for treating women with biopsy-proven cervical intraepithelial neoplasia 2/3.
Similar Researchers
Based on overlapping research topics
Grant Wangila
University of Arkansas at Pine Bluff
Cancer Treatment and Pharmacology
Plant Physiology and Cultivation Studies
Pharmacological Effects and Toxicity Studies
Jenat Rahman
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Plant Physiology and Cultivation Studies
Pharmacological Effects and Toxicity Studies
Mya Snyder
Maternal and Perinatal Health Interventions
Medical Education
Research and Education
Shariq Ali
University of Arkansas at Little Rock
Maternal and Perinatal Health Interventions
Cancer Treatment and Pharmacology
Pharmacological Effects and Toxicity Studies
Marsha F. Crader
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Medical Education
Research and Education
Erin Howie Hickey
University of Arkansas at Fayetteville
Maternal and Perinatal Health Interventions
Cancer Treatment and Pharmacology
Pharmacological Effects and Toxicity Studies